BIOVAXYS ANNOUNCES COMPLETION OF FIRST TRANCHE OF PRIVATE PLACEMENT
VANCOUVER, BC, Feb. 1, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys” or the “Company”) announces that it has completed the first tranche of a non-brokered private placement (the “Private Placement”) consisti
Proof of Authenticity in Digital Media: SWEAR Launches to Combat the Rise of Deepfakes
BOISE, Idaho, Feb. 1, 2024 /PRNewswire/ — Amid growing concerns over digital misinformation and the rise of deepfakes, SWEAR unveiled its groundbreaking technology at CES 2024, garnering interest from global government agencies, technology giants, and mobile communication leaders. This techno
Chemical Reactor Market Forecasts 2023-2028: Surge in Chemical Reactor Demand Amidst Rising Petrochemicals Need and Sustainability Measures
DUBLIN, Feb. 1, 2024 /PRNewswire/ — The “Chemical Reactor Market – Forecasts from 2023 to 2028” report has been added to ResearchAndMarkets.com’s offering. The latest comprehensive research on the Chemical Reactor Market now available provides a detailed insight into
Automotive Key Market Set for 7.9% CAGR Fueled by Tech Innovation & User Demand
NEWARK, Del., Feb. 1, 2024 /PRNewswire/ — Future Market Insights, Inc. (FMI) predicts a future where car keys are more than just metal blades, but rather sophisticated digital access tools propelling the automotive key market. Dive deeper into the intricate dynamics of this burgeoning market a
BetterInvesting™ Magazine Update on NXP Semiconductors N.V. and Comcast Corp.
TROY, Mich., Feb. 1, 2024 /PRNewswire/ — The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced NXP Semconductors N.V. (NASDAQ: NXPI) as its “Stock to Study” and Comcast Corp. (NASDAQ: CMCSA) as its “Undervalued Stock” in th
Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy
Experts in diabetes, pain and health services from the Worldwide Initiative for Diabetes Education recommend spinal cord stimulation when symptoms aren’t responsive to first- or second-line therapies REDWOOD CITY, Calif., Feb. 1, 2024 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global med
TETRA TECHNOLOGIES, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 EARNINGS RELEASE CONFERENCE CALL AND WEBCAST
THE WOODLANDS, Texas, Feb. 1, 2024 /PRNewswire/ — TETRA Technologies, Inc. (“TETRA” or the “Company”) (NYSE:TTI) announced today that it will release fourth quarter and full year 2023 results after the closing of the market on Tuesday, February 27, 2024. On February 2
Study on the safety of Elixinol Hemp Extract is published in Journal of Toxicology
SYDNEY, Feb. 2, 2024 /PRNewswire/ — Elixinol Wellness Limited (ASX: EXL) continues to be a pioneer in the global hemp industry, with the release of a new paper into the safety of Elixinol Hemp Extract in leading scientific publication, Journal of Toxicology. The paper, entitled “Safety
Ansys to Release Fourth Quarter and FY 2023 Earnings on February 21, 2024
PITTSBURGH, Feb. 1, 2024 /PRNewswire/ — ANSYS, Inc. (NASDAQ: ANSS) announced today that the Company expects to release its fourth quarter and FY 2023 earnings on Wednesday, February 21, 2024, after the market closes. In light of the pending transaction with Synopsys, Inc. (Synopsys), Ansys is
IGT Signs 12-Year Contract Extension with UAB Perlas Network in Lithuania to Deploy Upgraded Central System Software
LONDON, Feb. 1, 2024 /PRNewswire/ — International Game Technology PLC (“IGT”) (NYSE:IGT) today announced that its subsidiary, IGT Global Solutions Corporation, has extended its contract with UAB Perlas Network (“Perlas”) for an additional 12 years until 2035. As part of
